Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
None
A Study of ASP1570 in Adults With Advanced Solid Tumors

Part 1 without getting major medical problems. Some groups of people will have specific advanced tumors. These include tumors from metastatic melanoma or non-small cell lung cancer (NSCLC for short

  • 0 views
  • 01 Dec, 2021
  • 1 location
None
Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION

The trial is looking for new and better ways to treat melanoma, an aggressive type of skin cancer. Having surgery to remove the melanoma will cure the majority of patients with early stage

melanoma skin
malignant melanoma of skin
cancer
nivolumab
neutrophil count
  • 0 views
  • 25 Nov, 2021
  • 1 location
None
Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma

This is a patient oriented translational research project aiming to improve clinical outcomes for patients with BRAF and NRAS wild-type unresectable Stage III or Stage IV metastatic melanoma who

targeted therapy
mek inhibitor
metastatic melanoma
cancer
mucosal melanoma
  • 0 views
  • 03 Dec, 2021
  • 2 locations
None
Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma

first-line treatment or metastatic melanoma will be evaluated in phase Ib. Objective response rate (ORR) and progression-free survival (PFS) of ZKAB001 combined with RP2D's Pexa-Vec or ZKAB001

  • 0 views
  • 03 Dec, 2021
  • 1 location
None
Study of LVGN3616 and LVGN6501 LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

This is an investigator-initiated industry-supported phase 1 clinical trial conducted in the phase 1 clinic at The University of Texas MD Anderson Cancer Center who will hold the Investigational New Drug (IND). Lvygen Biopharma will provide as investigational supply LVGN3616, LVGN6051 and LVGN7409 at no cost to the patients on …

measurable disease
neutrophil count
bevacizumab
paclitaxel
taxane
  • 0 views
  • 05 Dec, 2021
  • 1 location
None
Observational Study for Melanoma Adjuvant Treatment With Tafinlar + Mekinist (Dabrafenib + Trametinib)

The primary objective for this non-interventional study is to assess the quality of life of melanoma patients under adjuvant treatment with dabrafenib and trametinib in real world setting in

immunologic adjuvant
trametinib
malignant melanoma of skin
dabrafenib
  • 0 views
  • 05 Dec, 2021
  • 6 locations
None
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

The microbiome has the potential to serve as a robust biomarker of clinical response to immunotherapy. Additionally, microbial manipulation, through diet, exercise, prebiotics, probiotics, or microbially-derived metabolites, may prove to be beneficial in promoting anti-tumor immune responses. However, large prospective studies in humans with longitudinal sample collection and standardized methods …

targeted therapy
programmed cell death 1 ligand 1
cancer
cytotoxic t-lymphocyte antigen 4
cancer chemotherapy
  • 0 views
  • 29 Nov, 2021
  • 1 location
None
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

cancer
chemotherapy regimen
  • 0 views
  • 03 Dec, 2021
  • 1 location